Reverse stock splits are often executed to increase the market price of a company's shares, making them more appealing to investors and potentially in compliance with stock exchange listing requirements. For Moleculin Biotech, this action has led to a positive short-term impact on its share price as it may improve investor perception and meet regulatory standards for minimum share price.